Big pharma and 21st Century drug development Free

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

x Mobile version: slides + audio only
-15s 00:00 / 23:51 +15s
Minimise video

Professor Bountra talks about the biggest challenges facing drug discovery regarding chronic and rare diseases. He also provides insight into what they have been working on in Oxford and what is to come in the future. 

This lecture was part of the 'Innovation in urology' meeting at the Royal Society of Medicine in London.

Date of lecture: 26th February 2016

Length: 00:23:51

00:00:01
51:06

Professor Sir Mark Walport, Director of the Wellcome Trust.

Archived View
35:53

Mr Ben Challacombe, Consultant Urological Surgeon at Guy's and St Thomas' NHS Foundation Trust.

 

Free Archived View
38:25

Professor Tom Waddell, Professor of Thoracic and Lung Transplant Surgery, University of Toronto.

Archived View
25:30

Professor Adrian Hill, Chairman of the Centre for Clinical Vaccinology and Tropical Medicine at Oxford University. 

Free Archived View
28:05

Dr Alun Morgan and Mrs Gill Davies, ZooBiotic.

Free Archived View
26:45

Dr Paul Sobotka, Ardian, California and Dr Mel Lobo, Barts and the London NHS Trust. 

Free Archived View
29:24

Peter Suma and Peter Ellis, Pharmatrust, Canada and the UK.

Free Archived View
37:46

Dr Frederic Moll, President and CEO Hansen Medical Inc, California.

Free Archived View
16:14

Professor Anan Shetty, Senior tutor in orthopaedics, University of London. 

Free Archived View